Fish diseases are a huge threat for the aquaculture industry and for global food security. Some of the most important disease-causing organisms in aquaculture are part of the oomycetes or watermoulds, in particular Saprolegnia parasitica, Saprolegnia diclina and Saprolegnia australis are causing serious fish losses. Collectively, these fungal-like organisms are responsible for at least 10% annual mortalities in most salmon hatcheries and freshwater sites. Consequently, Saprolegnia ranks among the most important pathogens of Atlantic salmon. Unfortunately, over the last few years the incidences of saprolegniosis outbreaks in Scottish farms have significantly increased. Indeed, some sites have had very high losses due to saprolegniosis. Whereas other farms have remained largely disease free. The reasons as to why some farms are badly affected and others seem to avoid disease outbreaks, with apparent identical welfare standards and husbandry management practises, are at present completely unclear and form the main rational for the current application. Our hypothesis is that several risk factors (pertaining to fish, pathogens and the environment) are playing a synergistic role in suppressing immunity in fish towards Saprolegnia, which lead to outbreaks of saprolegniosis. Therefore, we propose a concerted industry-wide, industry-led and industry-supported research programme to discover, map, model and understand the main drivers, risk factors, that allow saprolegniosis outbreaks. A "big data" resource will be created that will be scrutinised with statistical methods to identify the main risk factors and conditions for outbreaks of saprolegniosis. Undoubtedly, identifying the main, or a combination of, risk factors will greatly aid the salmon aquaculture industry to pre-empt any future outbreaks and would lead to an integrated approach to saprolegniosis management, which would result in increased welfare standards, improved fish health, fewer losses and a reduction in production and treatment costs.

The rapid expansion of the global Atlantic salmon industry has been made possible through the adoption of new farming technologies (land based Recirculating Aquaculture Systems, RAS) and husbandry regimes to manipulate animal physiology. This includes the parr-smolt transformation (the process by which salmon become seawater tolerant) and early maturation impacting on fish welfare and product quality. Salmon producers in the UK have either already built or are in the process of building such large production units. These systems have clear advantages over land-based or open water loch systems, including a reduction in water usage, improved management of waste, a better control of disease and the ability to manipulate environmental conditions for year round salmon production. However, questions about robustness of these fish when exposed to challenging natural conditions in open seawater cages have been emerging over recent years, especially for gill pathologies and a new anaemic syndrome. While the Industry and Government have strong aspirations for growth of the salmon sector to meet increasing market demands, considerable pressures are being experienced by the farming companies and production, at best, has stagnated over recent years and even decreased since 2015. This is mainly due to fish health challenges at sea resulting in emergency harvests and unsustainable losses at sea. From results obtained by the consortium research teams over the past 4 years, it appears very clearly that conditions experienced by fish early during freshwater development can impact on long-term performance and robustness at sea. The current project aims to characterise the impacts of freshwater environmental conditions including water chemistry, temperature, photoperiod and nutrition, between RAS and open water loch systems, on fish performance and overall health. The main hypothesis tested by the project is that early life history of salmon produced in freshwater RAS impacts on immune barriers (mainly gill, gut and skin), which may predispose fish to gill pathologies at sea. The project will investigate how RAS microbiota (e.g. microbe populations living in the fish intestine, gill and skin) and water chemistry (especially carbon dioxide) impact on fish immune function and performance. The effects of altered environmental regimes (photoperiod, temperature and diet) and vaccines that provide active protection against particular diseases at sea, will be tested on smolt immune function, performance and health following transfer to sea. Finally, the relationship between fish development in freshwater RAS and its impact upon commercial performance and overall health will be studied including the effects of the fish genetic makeup, the characterisation of the new anaemic syndrome and a large-scale epidemiological study. To ensure the success of the project, the consortium brings together world leading scientists from four of the main UK research Institutions working on aquaculture and sustainable livestock development in conjunction with the four leading salmon farming, feed manufacturing and pharmaceutical companies. The project has also a strong support from governmental research centres and industry led organisations. The research will enable the development of practical methods for the production of high quality salmon with benefits for animal welfare and the sustainability and profitability of the industry. Since farmed salmon are a major food source in the UK diet, with more than 1.2 million salmon meals eaten per day, this project also has great significance to the health and well-being of the population in the UK. By supporting the sustainable development of the salmon farming industry, this project will contribute to protect more than 9,000 directly employed and industry-associated jobs in largely rural areas of Scotland and will help create new jobs.